Lawsuit for Investors in shares of TG Therapeutics, Inc. (NASDAQ: TGTX) announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of TG Therapeutics, Inc. (NASDAQ: TGTX).

The plaintiff seeks to recover losses for certain investors who purchased TG Therapeutics, Inc. (NASDAQ: TGTX) shares.

Investors, who purchased shares of TG Therapeutics, Inc., have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

On September 25, 2018, TG Therapeutics announced ''that the independent Data Safety Monitoring Board (DSMB) for the UNITY-CLL Phase 3 trial met to review ongoing data from the study and advised the Company that the interim analysis of Overall Response Rate (ORR) could not be conducted at this time as the data were not sufficiently mature to conduct the analysis.''

The plaintiff alleges that the defendants failed to disclose that TG Therapeutics was involved in cleaning the data collected in the UNITY-CLL Trial and, as a result, was able to gain an understanding as to the efficacy of the combination therapy; that, as a result of that data cleaning, TG Therapeutics knew the UNITY-CLL Trial had failed to meet its stated goal, and that, as a result, the Company would not be able to seek accelerated approval; and that, given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival – in other words, the drug therapy had failed.

The plaintiff claims that as a result of defendants' false statements and/or omissions, the price of TG Therapeutics common stock was artificially inflated between June 4, 2018 and September 25, 2018 to as high as $14.70 per share.

Those who purchased TG Therapeutics, Inc. shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.

Source: Shareholders Foundation, Inc.

Share: